Osang Healthcare Co.,Ltd (KOSDAQ:036220)
South Korea · Delayed Price · Currency is KRW 6,750.00
-100.00 (-1.46%)
At close: Jun 5, 2026
Osang Healthcare Co.,Ltd Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -4,432 | 3,109 | -11,364 | 116,436 | 40,647 | 1,460 |
Depreciation & Amortization | 8,131 | 7,866 | 7,156 | 6,335 | 5,413 | 3,956 |
Loss (Gain) From Sale of Assets | -39.25 | -33.8 | -6.69 | 1,640 | -216.07 | -5.33 |
Asset Writedown & Restructuring Costs | 84.61 | 91.4 | 18.43 | 9.69 | 0.07 | 0.68 |
Loss (Gain) From Sale of Investments | -14.84 | 75.35 | 56.54 | 104.99 | 984.88 | -1,321 |
Loss (Gain) on Equity Investments | -433.78 | -652.65 | 2,791 | -925.89 | -259.8 | -913.21 |
Stock-Based Compensation | 1,036 | 963.93 | 1,348 | 1,860 | 2,696 | 3,094 |
Provision & Write-off of Bad Debts | 522.35 | -700.61 | -460.56 | 3,323 | 2,069 | 21,600 |
Other Operating Activities | -1,551 | -981.19 | -27,923 | 11,626 | 18,811 | -24,190 |
Change in Accounts Receivable | 6,271 | -6,578 | 1,804 | 20,216 | -18,527 | 1,128 |
Change in Inventory | 8,914 | 5,728 | -7,995 | 20,101 | -26,946 | 4,193 |
Change in Accounts Payable | -1,337 | 287.93 | -4,885 | -14,581 | 12,089 | -1,015 |
Change in Unearned Revenue | -2.96 | -0.43 | 11.33 | 9.9 | 5.81 | - |
Change in Other Net Operating Assets | -3,287 | -2,962 | 682.85 | -13,559 | 5,586 | 2,819 |
Operating Cash Flow | 13,862 | 6,213 | -38,767 | 152,596 | 42,353 | 10,807 |
Operating Cash Flow Growth | - | - | - | 260.29% | 291.90% | -89.32% |
Capital Expenditures | -15,908 | -16,094 | -27,810 | -35,703 | -11,702 | -9,040 |
Sale of Property, Plant & Equipment | 43.64 | 40.36 | 54.19 | 14,607 | 715.05 | 87.98 |
Sale (Purchase) of Intangibles | -2,823 | -2,915 | -4,629 | -179.72 | -199 | -858.77 |
Investment in Securities | -11,153 | -11,521 | -23,808 | -34,251 | -16,309 | 3,722 |
Other Investing Activities | -0 | - | 0 | 0 | - | 10 |
Investing Cash Flow | -29,841 | -30,490 | -56,192 | -55,526 | -27,495 | -6,079 |
Short-Term Debt Issued | - | - | - | 14,850 | - | 100 |
Long-Term Debt Issued | - | 43,913 | - | - | - | - |
Total Debt Issued | 18,948 | 43,913 | - | 14,850 | - | 100 |
Short-Term Debt Repaid | - | - | - | -14,850 | - | -2,100 |
Long-Term Debt Repaid | - | -577.91 | -477.49 | -592.47 | -625.08 | -302.05 |
Total Debt Repaid | -606.95 | -577.91 | -477.49 | -15,442 | -625.08 | -2,402 |
Net Debt Issued (Repaid) | 18,341 | 43,335 | -477.49 | -592.47 | -625.08 | -2,302 |
Issuance of Common Stock | - | 230.31 | 23,154 | 714.38 | 2,570 | 294.61 |
Repurchase of Common Stock | - | - | -4,994 | - | - | - |
Dividends Paid | -6,856 | -6,856 | -25,169 | -25,349 | -24,895 | -24,534 |
Other Financing Activities | -0 | -0 | 13.23 | - | - | 0 |
Financing Cash Flow | 11,485 | 36,709 | -7,473 | -25,227 | -22,950 | -26,541 |
Foreign Exchange Rate Adjustments | 310.65 | -204.87 | 2,180 | -366.29 | -874.74 | 18.02 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - |
Net Cash Flow | -4,183 | 12,227 | -100,253 | 71,476 | -8,966 | -21,795 |
Free Cash Flow | -2,046 | -9,881 | -66,577 | 116,893 | 30,651 | 1,768 |
Free Cash Flow Growth | - | - | - | 281.36% | 1634.00% | -98.11% |
Free Cash Flow Margin | -1.71% | -7.68% | -82.72% | 32.85% | 15.81% | 1.34% |
Free Cash Flow Per Share | -148.81 | -717.32 | -4903.48 | 8955.92 | 2387.99 | 143.73 |
Cash Interest Paid | 1,377 | 1,109 | 27.17 | 49 | 25.12 | 8.75 |
Cash Income Tax Paid | - | -1,333 | 17,022 | 33,836 | 1,311 | 36,540 |
Levered Free Cash Flow | -7,175 | -15,115 | -69,284 | 93,874 | 34,689 | 7,542 |
Unlevered Free Cash Flow | -6,482 | -14,422 | -69,267 | 93,910 | 34,705 | 7,552 |
Change in Working Capital | 10,558 | -3,524 | -10,382 | 12,187 | -27,792 | 7,125 |